| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-09 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-09 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |